Shankar, Sharmila <br/><br/>
EGCG inhibits growth of human pancreatic tumors orthotopically implanted in Balb C nude mice through modulation of FKHRL1/FOXO3a and neuropilin.  [electronic resource] 

 -  Molecular and cellular biochemistry  Jan 2013 
 - 83-94 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-4919 
<br/><br/><label>Standard No.: </label>10.1007/s11010-012-1448-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents, Phytogenic--pharmacology<br/>Apoptosis--drug effects<br/>Biomarkers, Tumor--genetics<br/>Carcinoma, Pancreatic Ductal--blood supply<br/>Catechin--analogs & derivatives<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Forkhead Box Protein O3<br/>Forkhead Transcription Factors--metabolism<br/>Gene Expression--drug effects<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>MAP Kinase Signaling System--drug effects<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Neovascularization, Pathologic--prevention & control<br/>Neuropilins--metabolism<br/>Pancreas--pathology<br/>Pancreatic Neoplasms--blood supply<br/>Proliferating Cell Nuclear Antigen--metabolism<br/>Tumor Burden--drug effects<br/>Xenograft Model Antitumor Assays